A biotech clash between the iShares Biotechnology ETF (IBB) and the SPDR S&P Biotech ETF (XBI). Which biotech stock fund is the better choice?

Image Source: Pixabay
Video Length: 00:14:30
A biotech clash between the iShares Biotechnology ETF and the SPDR S&P Biotech ETF.
A biotech clash between the iShares Biotechnology ETF (IBB) and the SPDR S&P Biotech ETF (XBI). Which biotech stock fund is the better choice?

Image Source: Pixabay
Video Length: 00:14:30
Ron DeLegge has analyzed and graded more than $125 million with his Portfolio Report Card grading system. Does your portfolio pass or fail? Find out and if you get an "A" Ron will pay you $100.
Comments
Log in or sign up to join the conversation.